why choose us

First received: February 14, 2023

Clinical Trial: Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women

Study Status: Completed

Recruit Status: RECRUITING

Condition: Breast Atypical Ductal Hyperplasia

Study Type: OBSERVATIONAL


Official Title: Genetic Risk Estimation in Breast Cancer and Assessing Health Disparities

Brief Summary: This study evaluates whether adding a polygenic risk score evaluation to standard breast cancer risk assessment tools helps African American and Hispanic women make more informed decisions about accepting additional breast cancer screening and prevention strategies.Traditional breast cancer risk assessments rely mostly on the presence of standard clinical risk factors including family history, reproductive history, and mammographic breast density.This information can be combined with validated risk estimation…

Read more